Search Results | Frontiers in Pharmaceutical Sciences

Home Results

A total of 4 result was found. Results that relate to Hepatocellular carcinoma

替雷利珠单抗较索拉非尼作为晚期不可切除肝细胞癌一线治疗的成本-效用分析

SU Zhan CHE Jinhui PEI Ruifeng

DOI：10.12173/j.issn.1008-049X.202312216

Hepatocellular carcinoma Tislelizumab Sorafenib Partition survival model Pharmacoeconomic analysis
Details Download Mobile
信迪利单抗联合贝伐珠单抗对晚期肝细胞癌的真实世界研究

SU Zhan CHE Jinhui PEI Ruifeng

DOI：10.12173/j.issn.1008-049X.202402057

Advanced hepatocellular carcinoma Sintilimab Bevacizumab Clinical efficacy Safety Overall survival Progression-free survival
Details Download Mobile
替雷利珠单抗联合索拉非尼治疗不可切除肝细胞性肝癌的疗效和安全性

JIANG Jinghua HU Yiting

DOI：10.12173/j.issn.1008-049X.202406071

Tirilizumab Sorafenib Unresectable Hepatocellular carcinoma Objective response rate Disease control rate Progression-free survival Overall survival
Details Download Mobile
基于文献挖掘探析肝癌前病变的中医临床用药规律

GOU Siyuan YANG Xianzhao WANG Longzhu TIAN Yujia RU Shuying

DOI：10.12173/j.issn.2097-4922.202405139

Hepatocellular carcinoma Precancerous lesions Traditional Chinese medicine Data mining Medication rule Milkvetch root Largehead atractylodes rhizome Radix salviae miltiorrhhizae
Details Download Mobile